By preventing CXCL12/CXCR4 crosstalk, exposure to plerixafor resulted in reduced ERK1/2 signaling and consequently, decreased proliferation and invasion of disseminated tumor cells (Figure 2). This evidence concerns the gene MAPK3 and neoplasm.